| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $250.32M | $272.72M | $293.14M | $272.56M | $356.91M |
| R&D | $131.98M | $217.56M | $268.82M | $285.88M | $248.63M |
| SG&A | $44.30M | $64.04M | $73.30M | $71.56M | $50.41M |
| Operating Income | -$250.32M | -$272.72M | -$293.14M | -$272.56M | -$356.91M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | – | – | – | – |
| Net Income | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M |
| EPS (basic) | -0.9600 | -1.1600 | -1.4600 | -1.4300 | -2.1400 |
| EPS (diluted) | -0.9600 | -1.1600 | -1.4600 | -1.4300 | -2.1400 |
| Shares (diluted) | $253.23M | $230.89M | $194.54M | $188.34M | $166.43M |